Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...
A digital therapeutic (DTx) that aims to treat negative symptoms of schizophrenia, like apathy and social withdrawal, has hit the target in a phase 3 trial. The smartphone-based CT-155 app, ...
2 IU Center for Sports Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Correspondence to: Dr Thomas H Trojian University of Connecticut Health Center/Saint Francis Hospital ...
The Aviationist on MSN
Leonardo’s Next Generation Civil Tiltrotor Demonstrator Makes First Flight in Italy
The NGCTR demonstrator is designed to mature key novel technologies that could support the development of a larger civil tiltrotor with lower emissions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback